Dose Escalation Complete in Kidney Cancer Trial of HC-7366 Plus Welireg
A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation portion of the clinical trial.
Related Articles
Inspirational Leader Shines Her Light Outward to Others
Dr. Susan Rux, a respected nursing leader and researcher, empowers teams, mentors future leaders, and advances inclusive clinical research in kidney cancer.
HT-KIT Shows Activity in Rare KIT-Driven Cancers, Preclinical Data Finds
Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, including GIST and some leukemias.
Warning against extending police detention powers to nurses | Nursing Times
Read about a joint statement by health groups including the RCN warning against amendments to the Mental Health Bill related to dentention.
Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer
ATR-04 therapy is being investigated in the phase 1/2 ATR04-484 clinical trial for the treatment of EGFR inhibitor-associated rashes in lung cancer.
Cardiff nursing staff no longer at risk of redundancy | Nursing Times
Read about news that nursing staff at Cardiff University are no longer at risk of redundancy as part of its programme of cuts.
Warning against extending police detention powers to nurses | Nursing Times
Read about a joint statement by health groups including the RCN warning against amendments to the Mental Health Bill related to dentention.
Scottish nurses doubtful about ability to meet safe staffing law | Nursing Times
Find out the results of a survey of nurses about their views on being able to meet the Health and Care (Staffing) (Scotland) Act.
Scottish nurses doubtful about ability to meet safe staffing law | Nursing Times
Find out the results of a survey of nurses about their views on being able to meet the Health and Care (Staffing) (Scotland) Act.
The passing and legacy of one of the ‘giants’ of British nursing | Nursing Times
Win Logan, who died aged 98 on 2 April 2025, was a much liked and highly respected member of the nursing profession. Read about her…
Preparing For Survivorship After Lymphoma Treatment in AYA PatientsPreparing For Survivorship After Lymphoma Treatment in AYA Patients
Dr. Kara Kelly discusses specific long-term health considerations that AYA survivors of lymphoma should be aware of to best prepare for survivorship.